Literature DB >> 8619425

Strongyloides stercoralis eosinophilic granulomatous enterocolitis.

Y Gutierrez1, P Bhatia, S T Garbadawala, J R Dobson, T M Wallace, T E Carey.   

Abstract

Six patients suffering from an unusual form of colitis produced by Strongyloides stercoralis hyperinfection are described. In contrast to the usual Strongyloides hyperinfection syndrome, in which small intestinal and pulmonary manifestations are seen in patients with some forms of immunodeficiency, the patients described here presented with only a characteristic transmural eosinophilic granulomatous inflammation affecting mostly the colonic wall and clinically mimicking ulcerative colitis or Crohn's disease. This Strongyloides eosinophilic granulomatous enterocolitis apparently results from a florid inflammatory response by eosinophils, histiocytes, and giant cells with formation of granulomas that destroy the larvae entering the colon. This morphologic picture differs from that of the well-described hyperinfection syndrome, in which the bulk of the larvae pass through the colonic wall to complete the life cycle, with only a few larvae destroyed in the colon. The probable pathophysiologic mechanism of this unusual manifestation of hyperinfection is discussed based on the anatomic and clinical observations of patients who presented at different stages in the evolution of their condition and whose length of follow-up varied.

Entities:  

Mesh:

Year:  1996        PMID: 8619425     DOI: 10.1097/00000478-199605000-00007

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  12 in total

Review 1.  Duodenal obstruction caused by Strongyloides stercoralis enteritis in an HTLV-1-infected host.

Authors:  F Friedenberg; N Wongpraparut; R A Fischer; J Gubernick; N Zaeri; G Eiger; Z Ozden
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

Review 2.  Granulomas in the gastrointestinal tract: deciphering the Pandora's box.

Authors:  Ian Brown; Marian Priyanthi Kumarasinghe
Journal:  Virchows Arch       Date:  2017-08-04       Impact factor: 4.064

3.  Strongyloides stercoralis hyperinfection syndrome and disseminated disease.

Authors:  Marco Kassalik; Klaus Mönkemüller
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-11

Review 4.  New insights into gastrointestinal and hepatic granulomatous disorders.

Authors:  Majid A Almadi; Abdulrahman M Aljebreen; Faisal M Sanai; Victoria Marcus; Ebtissam S Almeghaiseeb; Subrata Ghosh
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-08-05       Impact factor: 46.802

5.  Flare-up of ulcerative colitis after systemic corticosteroids: a strong case for Strongyloides.

Authors:  Shomron Ben-Horin; Iris Barshack; Yehuda Chowers; Meir Mouallem
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

Review 6.  Strongyloides stercoralis hyperinfection syndrome: a case series and a review of the literature.

Authors:  Guillaume Geri; Antoine Rabbat; Julien Mayaux; Lara Zafrani; Ludivine Chalumeau-Lemoine; Bertrand Guidet; Elie Azoulay; Frédéric Pène
Journal:  Infection       Date:  2015-05-26       Impact factor: 7.455

7.  An Update on the Geohelminths: Ascaris lumbricoides, Hookworms, Trichuris trichiura, and Strongyloides stercoralis.

Authors:  Richard D. Pearson
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.663

8.  Intestinal strongyloidiasis and hyperinfection syndrome.

Authors:  Raja S Vadlamudi; David S Chi; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2006-05-30

9.  Strongyloides stercoralis hyperinfection associated with impaired intestinal motility disorder.

Authors:  Cláudia Frangioia Figueira; Márcio Teodoro da Costa Gaspar; Lynda Dorene Cos; Edson Yassushi Ussami; José Pinhata Otoch; Aloisio Felipe-Silva
Journal:  Autops Case Rep       Date:  2015-06-30

Review 10.  Severe strongyloidiasis: a systematic review of case reports.

Authors:  Dora Buonfrate; Ana Requena-Mendez; Andrea Angheben; Jose Muñoz; Federico Gobbi; Jef Van Den Ende; Zeno Bisoffi
Journal:  BMC Infect Dis       Date:  2013-02-08       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.